All Issue

2020 Vol.1, Issue 1 Preview Page
31 January 2020. pp. 16-22
Abstract
Sorry, not available.
Click the PDF button.
References
1
Baillargeon J, Urban RJ, Ottenbacher KJ, Pierson KS, Goodwin JS. Trends in androgen prescribing in the United States, 2001 to 2011. JAMA Intern Med. 2013; 173: 1465-6.
10.1001/jamainternmed.2013.689523939517PMC4100547
2
Vigen R, O'Donnell CI, Baron AE, Grunwald GK, Maddox TM, Bradley SM, et al. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA 2013; 310: 1829- 36.
10.1001/jama.2013.28038624193080
3
Morales A, Bain J, Ruijs A, Chapdelaine A, Tremblay RR. Clinical practice guidelines for screening and monitoring male patients receiving testosterone supplementation therapy. Int J Impot Res 1996; 8: 95-7.
4
Lunenfeld B, Mskhalaya G, Zitzmann M, Arver S, Kalinchenko S, Tishova Y. Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men. Aging Male 2015; 18: 5-15.
10.3109/13685538.2015.100404925657080PMC4648196
5
Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, et al. Testosterone therapy in men with hypogonadism: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2018: 103: 1715-44.
10.1210/jc.2018-0022929562364
6
Khera M, Adaikan G, Buvat J, Carrier S, El-Meliegy A, Hatzimouratidis K, et al. Diagnosis and treatment of testosterone deficiency: Recommendations from the fourth international consultation for sexual medicine (ICSM 2015). J Sex Med. 2016; 13: 1787-804.
10.1016/j.jsxm.2016.10.00927914560
7
Mulhall JP, Trost LW, Brannigan RE, Kurtz EG, Redmon JB, Chiles KA, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol 2018; 200: 423-32.
10.1016/j.juro.2018.03.11529601923
8
Moon DG, Kim JW, Kim JJ, Park KS, Park JK, Park NC, et al. Prevalence of symptoms and associated comorbidities of testosterone deficiency syndrome in the Korean general population. J Sex Med 2014; 11: 583-94.
10.1111/jsm.1239324274237
9
Patel AS, Leong JY, Ramos L, Ramasamy R. Testosterone is a contraceptive and should not be used in men who desire fertility. World J Mens Health 2019; 37: 45-54.
10.5534/wjmh.18003630350483PMC6305868
10
Corona G, Maseroli E, Rastrelli G, Isidori AM, Sforza A, Mannucci E, et al. Cardiovascular risk associated with testosterone-boosting medications: A systematic review and meta-analysis. Expert Opin Drug Saf. 2014; 13: 1327- 51.
10.1517/14740338.2014.95065325139126
Information
  • Publisher :The Association of Korean Urologists
  • Publisher(Ko) :대한비뇨의학과의사회
  • Journal Title :비뇨의학 Urology Digest
  • Volume : 1
  • No :1
  • Pages :16-22